Delivery Order SPE2DB22D1017-SPE2DB24FF5PB
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of TRELEGY ELLIPTA 200-62.5-25 60S pharmaceutical products. The $1,526.98 delivery order has a completion date of February 23, 2024. Amerisourcebergen Drug Corp holds a larger indefinite delivery contract with DLA Troop Support Medical, valued up to $999,999,999.00, to provide a wide range of pharmaceutical products and...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of TRELEGY ELLIPTA 100-62.5-25 60S prescription medication. The $12,193.62 firm fixed price contract has an ultimate completion date of April 23, 2024 and is not set aside for any small business designation. Amerisourcebergen is fulfilling this order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TRELEGY ELLIPTA 100-62.5-25 60S pharmaceutical products. The contract has a potential value of $6,767.40 and a performance period through January 29, 2024. This delivery order is issued under Amerisourcebergen Drug Corp's existing indefinite delivery contract (IDC) with DLA, which has a potential value of $999,999,999.00...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide TRELEGY ELLIPTA 100-62.5-25 60S pharmaceutical products. The $6,322.28 contract has an ultimate completion date of April 11, 2024. AmerisourceBergen Drug Corp is the prime contractor and holds a $999,999,999.00 indefinite delivery contract with DLA to provide a comprehensive range of pharmaceutical products and...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide TRELEGY ELLIPTA 200-62.5-25 60S pharmaceutical products. The award, valued at $1,591.22, has an ultimate completion date of March 29, 2024. AmerisourceBergen Drug Corp is the prime contractor, with no set-aside designation. This delivery order is associated with an indefinite delivery contract awarded by DLA to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $6,068.70 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of TRELEGY ELLIPTA 200-62.5-25 60S pharmaceutical products. This delivery order contract has an ultimate completion date of April 12, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4564147460 - TRELEGY ELLIPTA 100-62.5-25 60S pharmaceutical products. The award, valued at $7,194.39, has an ultimate completion date of April 3, 2024. Amerisourcebergen Drug Corp is the prime contractor and has an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025,...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a division of the global pharmaceutical distributor Amerisourcebergen Corporation, to provide TRELEGY ELLIPTA 200-62.5-25 60S medication. The $26,055.97 contract has a performance period through March 19, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TRELEGY ELLIPTA 200-62.5-25 60S pharmaceutical products. The contract has a potential value of $1,310.98 and a completion date of March 1, 2024. Amerisourcebergen Drug Corp is the prime contractor and there were no set-aside designations used for this award. The contract is part of a larger indefinite delivery contract...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The $2,961.48 contract is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a specialty pharmaceutical product. The award does not have a set-aside designation. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA valued at up to $999,999,999.00, which serves...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB24FF5PBDelivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of TRELEGY ELLIPTA 100-62.5-25 60S pharmaceutical products. The delivery order, valued at $2,369.21, has an ultimate completion date of April 9, 2024. This contract is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 4/8/24 |